Cargando…

Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination

Therapy-induced resistance remains a significant hurdle to achieve long-lasting responses and cures in cancer patients. We investigated the long-term consequences of genetically impaired angiogenesis by engineering multiple tumor models deprived of endoglin, a co-receptor for TGF-β in endothelial ce...

Descripción completa

Detalles Bibliográficos
Autores principales:	Anderberg, Charlotte, Cunha, Sara I., Zhai, Zhenhua, Cortez, Eliane, Pardali, Evangelia, Johnson, Jill R., Franco, Marcela, Páez-Ribes, Marta, Cordiner, Ross, Fuxe, Jonas, Johansson, Bengt R., Goumans, Marie-José, Casanovas, Oriol, ten Dijke, Peter, Arthur, Helen M., Pietras, Kristian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Rockefeller University Press 2013
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600899/ https://www.ncbi.nlm.nih.gov/pubmed/23401487 http://dx.doi.org/10.1084/jem.20120662

Ejemplares similares

Shear induced collateral artery growth modulated by endoglin but not by ALK1
por: Seghers, Leonard, et al.
Publicado: (2012)

Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis
por: Cunha, Sara I., et al.
Publicado: (2010)

ENDOGLIN Is Dispensable for Vasculogenesis, but Required for Vascular Endothelial Growth Factor-Induced Angiogenesis
por: Liu, Zhen, et al.
Publicado: (2014)

TGFβ Signaling and Cardiovascular Diseases
por: Pardali, Evangelia, et al.
Publicado: (2012)

Endoglin: Beyond the Endothelium
por: Schoonderwoerd, Mark J. A., et al.
Publicado: (2020)

Compound genetically engineered mouse models of cancer reveal dual targeting of ALK1 and endoglin as a synergistic opportunity to impinge on angiogenic TGF-β signaling
por: Eleftheriou, Nikolas M., et al.
Publicado: (2016)

TGF-β-Induced Endothelial-Mesenchymal Transition in Fibrotic Diseases
por: Pardali, Evangelia, et al.
Publicado: (2017)

Role of soluble endoglin in BMP9 signaling
por: Lawera, Aleksandra, et al.
Publicado: (2019)

Endoglin (CD105) and VEGF as potential angiogenic and dissemination markers for colorectal cancer
por: Nogués, Ana, et al.
Publicado: (2020)

Regulatory RNAs controlling vascular (dys)function by affecting TGF-ß family signalling
por: Kurakula, Kondababu, et al.
Publicado: (2015)

Enhanced cytotoxic T lymphocytes recruitment targeting tumor vasculatures by endoglin aptamer and IP-10 plasmid presenting liposome-based nanocarriers
por: Yang, Xiaomei, et al.
Publicado: (2019)

BMP Receptor Inhibition Enhances Tissue Repair in Endoglin Heterozygous Mice
por: Bakker, Wineke, et al.
Publicado: (2021)

MMP-15 Is Upregulated in Preeclampsia, but Does Not Cleave Endoglin to Produce Soluble Endoglin
por: Kaitu’u-Lino, Tu’uhevaha J., et al.
Publicado: (2012)

Low oxygen tension positively influences cardiomyocyte progenitor cell function
por: van Oorschot, Angelique A M, et al.
Publicado: (2011)

The Role of Endoglin in Hepatocellular Carcinoma
por: Jeng, Kuo-Shyang, et al.
Publicado: (2021)

Endoglin in the Spotlight to Treat Cancer
por: González Muñoz, Teresa, et al.
Publicado: (2021)

Endoglin in head and neck neoplasms
por: Litwiniuk-Kosmala, Małgorzata, et al.
Publicado: (2023)

Endoglin and squamous cell carcinomas
por: Hakuno, Sarah K., et al.
Publicado: (2023)

TGF-β-Induced Endothelial to Mesenchymal Transition in Disease and Tissue Engineering
por: Ma, Jin, et al.
Publicado: (2020)

Weakening HIV
por: Bashyam, Hema
Publicado: (2008)

Weakened defences
por: Whyte, Chelsea
Publicado: (2020)

Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review
por: Sier, Vincent Q., et al.
Publicado: (2021)

The roles of endoglin gene in cerebrovascular diseases
por: Zhu, Wan, et al.
Publicado: (2017)

Endoglin and TGF-β signaling in glioblastoma
por: Burghardt, Isabel, et al.
Publicado: (2021)

Chronic stress in mice remodels lymph vasculature to promote tumour cell dissemination
por: Le, Caroline P., et al.
Publicado: (2016)

Antibody-directed coupling of endoglin and MMP-14 is a key mechanism for endoglin shedding and deregulation of TGF-β signaling
por: Kumar, S, et al.
Publicado: (2014)

Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies
por: Nolan-Stevaux, Olivier, et al.
Publicado: (2012)

Age-dependent alteration of TGF-β signalling in osteoarthritis
por: van der Kraan, Peter M., et al.
Publicado: (2011)

Expression of endoglin (CD105) in cervical cancer
por: Zijlmans, H J, et al.
Publicado: (2009)

Contrasting Roles of Different Endoglin Forms in Atherosclerosis
por: Jang, Young-Saeng, et al.
Publicado: (2014)

Endoglin: a critical mediator of cardiovascular health
por: Kapur, Navin K, et al.
Publicado: (2013)

The Role of the TGF-β Coreceptor Endoglin in Cancer
por: Pérez-Gómez, Eduardo, et al.
Publicado: (2010)

Endoglin Targeting: Lessons Learned and Questions That Remain
por: Liu, Yingmiao, et al.
Publicado: (2020)

The Metalloprotease Meprinβ Processes E-Cadherin and Weakens Intercellular Adhesion
por: Huguenin, Maya, et al.
Publicado: (2008)

Smad7 and protein phosphatase 1α are critical determinants in the duration of TGF-β/ALK1 signaling in endothelial cells
por: Valdimarsdottir, Gudrun, et al.
Publicado: (2006)

Mimicking Cardiac Fibrosis in a Dish: Fibroblast Density Rather than Collagen Density Weakens Cardiomyocyte Function
por: van Spreeuwel, Ariane C.C., et al.
Publicado: (2017)

Endothelial Depletion of Acvrl1 in Mice Leads to Arteriovenous Malformations Associated with Reduced Endoglin Expression
por: Tual-Chalot, Simon, et al.
Publicado: (2014)

Coping strategies weaken cells
por: LeBrasseur, Nicole
Publicado: (2006)

Intermittent Weakness and Mediastinal Weakening
por: Malik, Umer Feroze, et al.
Publicado: (2009)

Hypotheses of Cancer Weakening and Origin
por: CHAN, John Cheung Yuen
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_ceisa2m7un3frdkrcqag0f059s